Optovue Stock

optovue.comHealthcareFounded: 2003Funding to Date: $44.77MM

Optovue is a medical device company focused on developing the next generation of ophthalmic optical coherence tomography (OCT) instruments.

Register for Details

For more details on financing and valuation for Optovue, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

By registering, you agree to the Forge Terms of Use. Already registered? Click here to log in

Enterprise Value (based on primary financings)

Enterprise Value

View Enterprise Value for Optovue.

Register Today

Team

Management Team

David Voris
President & Chief Financial Officer
Dragos Stanescu
Director, Mechanical Engineering
Jay Wei
Chief Executive Officer, Founder and President
Larry Alexander
Senior Director, Clinical Education

Other companies like Optovue in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.6B
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$150MM
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$296.3MM
Sector
Last Round Est. Valuation
$4.8B

News

FREMONT, Calif.—Optovue, Inc., a global leader in the development and commercialization of optical coherence tomography (OCT) and OCT angiography technology for the eyecare market, announced it has executed an agreement to receive $30 million in private equity funding from Deltronics (Netherlands) B.V., a subsidiary of Taiwan-based Delta Electronics, Inc., a global leader in power and thermal management solutions.